Mounjaro and Sleep Apnea: What People on Treatment Are Asking

Obstructive sleep apnea is a condition in which the airway becomes partially or fully blocked during sleep, causing repeated interruptions to breathing. Excess body weight — particularly around the neck and upper airway — is one of the most commonly cited contributing factors, according to NHS guidance on sleep apnea.

Because weight loss can reduce the fatty tissue around the airway, many people find that meaningful weight changes positively affect their sleep apnea symptoms. This is a general, well-recognised relationship, not a guarantee: the degree of benefit varies from person to person, and sleep apnea has multiple causes beyond weight alone.

Where Mounjaro fits in

Mounjaro is a prescription-only, once-weekly injectable medicine containing tirzepatide, a dual GIP and GLP-1 receptor agonist. It is prescribed for weight management in people who meet specific clinical criteria, as determined by a prescriber. The connection people are asking about — whether weight loss through tirzepatide might reduce sleep apnea severity — is an active area of research. Clinical trials have explored this, and you may have seen news coverage as a result.

It is important to be clear: Mounjaro is prescribed by your doctor for the indication they have agreed with you. Whether it is appropriate for any sleep-apnea-related purpose, and what that means for your own care, is a conversation to have with your prescriber — not something to act on based on general information.

For more on how Mounjaro is used as a weight management medicine, see our Mounjaro overview. If you are curious about how your sleep may be changing during your treatment, the page on Mounjaro and sleep quality covers what many people commonly experience.

What about approval status and insurance coverage?

Questions like "when will Mounjaro be approved for sleep apnea" and "will insurance cover Mounjaro for sleep apnea" reflect real concerns for people navigating their treatment. Approval status and coverage decisions vary by country, by healthcare system, and by individual clinical circumstances — and they change over time. Your prescriber or doctor, and where relevant a registered pharmacist, are the right people to ask about what applies to your specific situation and location. We do not quote prices or coverage figures anywhere on this site.

One of the most useful things you can do while on a weight-loss medicine is build a clear picture of how your body is changing — including how you are sleeping. That record can be genuinely valuable to bring to your prescriber appointments.

GLP Trackr's daily morning check-in lets you log sleep quality alongside weight, energy levels, mood, and how much "food noise" you noticed the day before. Over time, those check-ins build into a pattern — and if your sleep is improving as your weight changes, you will be able to see that clearly rather than relying on memory.

The app also includes weight and body tracking with charts, so you can follow your progress week by week in a way that goes beyond the number on the scale. And if you want to share a summary with your prescriber, the doctor report feature pulls your logged data into a clear overview — useful for exactly the kind of conversation where sleep apnea and weight progress might come up.

You can also explore how Mounjaro commonly affects rest more broadly on our page about sleep changes on Mounjaro, or read more specifically about Mounjaro and sleep apnea for a deeper look at the research context.

If you have sleep apnea, always follow the management plan your healthcare professional has put in place — including any CPAP or other therapy you have been prescribed. Weight changes can affect sleep apnea, but decisions about adjusting your treatment should be made with your prescriber, not independently.

Start logging your sleep, weight, and daily wellbeing in GLP Trackr — available free on the App Store and Google Play, with a 7-day free trial so you can see how it works for your journey.